BD POSIFLUSH¿ PRE-FILLED SALINE SYRINGE
Report
- Report Number
- 9616657-2022-00048
- Event Type
- Death
- Date Received
- December 15, 2022
- Date of Event
- November 25, 2022
- Report Date
- February 1, 2023
- Manufacturer
- BECTON, DICKINSON AND CO.
- Product Code
- NGT
- PMA / PMN Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. MULTIPLE LOT NUMBERS: THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH ADDITIONAL LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 1196818. MEDICAL DEVICE EXPIRATION DATE: 30-JUN-2024. DEVICE MANUFACTURE DATE: (B)(6) 2021. MEDICAL DEVICE LOT #: 1251978. MEDICAL DEVICE EXPIRATION DATE: 31-AUG-2024. DEVICE MANUFACTURE DATE: (B)(6) 2021.
THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D10: DEVICE AVAILABLE FOR EVAL YES. D10: RETURNED TO MANUFACTURER ON: 01-DEC-2022. H6: INVESTIGATION SUMMARY: TO AID IN THE INVESTIGATION OF THIS ISSUE, SIX (6) 10ML SYRINGES AND SIX (6) 5ML SYRINGES WERE RETURNED FOR EVALUATION BY OUR QUALITY ENGINEER TEAM. ALL OF THE TWELVE (12) SYRINGES WERE RECEIVED IN THEIR ORIGINAL, UNOPENED BLISTER PACKAGING. HOWEVER, ONLY FOUR (4) OF THE SYRINGES BELONGED TO THE LOT NUMBERS REPORTED IN THIS EVENT. UNFORTUNATELY, TESTING WAS NOT CONDUCTED ON THE RETURNED SAMPLES, AS THEY WERE NOT CONTROLLED/HANDLED APPROPRIATELY DURING THE SHIPMENT RETURN PROCESS. THE RETURNED SAMPLES WERE LOOSE WITHIN A COURIER BAG OUTSIDE OF THEIR ORIGINAL SECONDARY PACKAGING (SHELF CARTON), SO IT COULD NOT BE DETERMINED IF THE STERILITY BARRIER OF THE PACKAGE HAD BEEN BREACHED OR DAMAGED IN TRANSIT. A DEVICE HISTORY RECORD REVIEW WAS COMPLETED FOR PROVIDED MATERIAL NUMBER 306582 AND BATCH NUMBERS 1196818 AND 1251978. THE REVIEW DID NOT REVEAL ANY NON-CONFORMANCES DURING THE PRODUCTION PROCESS THAT COULD HAVE CONTRIBUTED TO THE REPORTED INCIDENT.
IT WAS REPORTED THAT THERE WAS A DEATH WHILE USING BD POSIFLUSH¿ PRE-FILLED SALINE SYRINGE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: PATIENT DIED DUE TO SEPSIS WHICH INITIATE AN ENVIRONMENTAL SCREENING FOR THE PATIENT CARE SETTING INCLUDING POSIFLUSH. PATIENT DIED DUE TO SEPSIS WHICH INITIATE A COMPLETE ENVIRONMENTAL SCREENING FOR SETTING FOR THE UNITS INCLUDING THE PREFILLED SYRINGES (POSIFLUSH 10 ML XS.
IT WAS REPORTED THAT THERE WAS A DEATH WHILE USING BD POSIFLUSH¿ PRE-FILLED SALINE SYRINGE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: PATIENT DIED DUE TO SEPSIS WHICH INITIATE AN ENVIRONMENTAL SCREENING FOR THE PATIENT CARE SETTING INCLUDING POSIFLUSH. PATIENT DIED DUE TO SEPSIS WHICH INITIATE A COMPLETE ENVIRONMENTAL SCREENING FOR SETTING FOR THE UNITS INCLUDING THE PREFILLED SYRINGES (POSIFLUSH 10 ML XS).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2570464 | BD POSIFLUSH¿ PRE-FILLED SALINE SYRINGE | PREFILLED SALINE SYRINGE | NGT | BECTON, DICKINSON AND CO. | SEE H.10 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Death |